Effect of Acute Stroke Care Regionalization on Intravenous Alteplase Use in Two Urban Counties - PubMed

Effect of Acute Stroke Care Regionalization on Intravenous Alteplase Use in Two Urban Counties - PubMed

Effect of Acute Stroke Care Regionalization on Intravenous Alteplase Use in Two Urban Counties

Prasanthi Govindarajan, Stephen Shiboski, Barbara Grimes, Lawrence J Cook, David Ghilarducci, Tong Meng, Amber W Trickey

• PMID: 31599705
 
• DOI: 10.1080/10903127.2019.1679303

Abstract

AbstractImportance: Intravenous alteplase is an effective treatment for acute ischemic stroke and is significantly underutilized. It is known that stroke centers with accreditation are more likely to provide intravenous alteplase treatment, and therefore, policies that increase the number of certified stroke centers and the number of acute ischemic stroke patients routed to these centers may be beneficial. Objective: To determine whether increasing access to primary stroke centers (regionalization) led to an increase in intravenous alteplase use in acute ischemic stroke patients. Design: An observational, longitudinal study to examine treatment trends with log-link binomial regression modeling to compare pre-post policy implementation changes in the proportions of patients treated with intravenous alteplase in two counties. Setting: Two urban counties, Santa Clara and San Mateo, in the western region of US that regionalized acute stroke care between 2005 and 2010. Participants: Patients with primary or secondary diagnosis of stroke were identified from the statewide patient discharge database by International Classification of Diseases (ICD-9) codes. We linked ambulance and hospital data to create complete patient care records. Main outcomes and measures: Stroke treatment, defined as a documented primary procedure code for intravenous alteplase administration (ICD-9: 99.10). Results: In Santa Clara County, intravenous alteplase was administered to 35 patients (1.7%) in the pre-regionalization period and 240 patients (2.1%) in the post-regionalization period. In San Mateo County, intravenous alteplase was administered to 29 patients (1.3%) in the pre-policy period and 135 patients (3.2%) in the post-policy period. After regionalization of stroke care, intravenous alteplase increased two-fold in San Mateo County [adjusted RR 2.20, p = 0.003, 95% CI (1.31, 3.69)] but did not show any statistically significant change in Santa Clara County [adjusted RR 1.10, p = 0.55, 95% CI (0.80, 1.51)]. In the post-regionalization phase, when compared with Santa Clara County, we found that San Mateo County had greater change in paramedic stroke detection, higher number of transports to primary stroke centers and more frequent use of intravenous alteplase at stroke centers. Conclusions: Our findings suggest that greater post-regionalization improvements in San Mateo County contributed to significantly better county-level thrombolysis use than Santa Clara County.

Keywords: ambulance; emergency medical services; stroke.

Similar articles

• Association of Clinical, Imaging, and Thrombus Characteristics With Recanalization of Visible Intracranial Occlusion in Patients With Acute Ischemic Stroke.

  Menon BK, Al-Ajlan FS, Najm M, Puig J, Castellanos M, Dowlatshahi D, Calleja A, Sohn SI, Ahn SH, Poppe A, Mikulik R, Asdaghi N, Field TS, Jin A, Asil T, Boulanger JM, Smith EE, Coutts SB, Barber PA, Bal S, Subramanian S, Mishra S, Trivedi A, Dey S, Eesa M, Sajobi T, Goyal M, Hill MD, Demchuk AM; INTERRSeCT Study Investigators.JAMA. 2018 Sep 11;320(10):1017-1026. doi: 10.1001/jama.2018.12498.PMID: 30208455 Free PMC article. Clinical Trial.
• The effectiveness of thrombolysis with intravenous alteplase for acute ischemic stroke in daily practice.

  Dirks M, Niessen LW, van Wijngaarden J, Koudstaal PJ, Franke CL, van Oostenbrugge RJ, Dippel DW; PRACTISE investigators.Int J Stroke. 2012 Jun;7(4):289-92. doi: 10.1111/j.1747-4949.2011.00709.x. Epub 2011 Dec 14.PMID: 22168317 Clinical Trial.
• Evaluation of animal control measures on pet demographics in Santa Clara County, California, 1993-2006.

  Kass PH, Johnson KL, Weng HY.PeerJ. 2013 Feb 19;1:e18. doi: 10.7717/peerj.18. Print 2013.PMID: 23638352 Free PMC article.
• Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials.

  Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, Brott T, Cohen G, Davis S, Donnan G, Grotta J, Howard G, Kaste M, Koga M, von Kummer R, Lansberg M, Lindley RI, Murray G, Olivot JM, Parsons M, Tilley B, Toni D, Toyoda K, Wahlgren N, Wardlaw J, Whiteley W, del Zoppo GJ, Baigent C, Sandercock P, Hacke W; Stroke Thrombolysis Trialists' Collaborative Group.Version 2. Lancet. 2014 Nov 29;384(9958):1929-35. doi: 10.1016/S0140-6736(14)60584-5. Epub 2014 Aug 5.PMID: 25106063 Free PMC article. Review.
• Readministration of intravenous alteplase in acute ischemic stroke patients: case series and systematic review.

  Qureshi AI, Malik AA, Freese M, Thompson MJ, Khan AA, Suri MF.Am J Emerg Med. 2015 Feb;33(2):307.e1-4. doi: 10.1016/j.ajem.2014.07.020. Epub 2014 Jul 31.PMID: 25190550 Review.